Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

BACKGROUND: Prior Studies have suggested better outcomes in smokers compared with nonsmokers receiving clopidogrel (“smoker's paradox”). The impact of a more intensive clopidogrel regimen on ischemic and bleeding risks in smokers with acute coronary syndromes requiring percutaneous coronary int...

Descripción completa

Detalles Bibliográficos
Autores principales: Bossard, Matthias, Granger, Christopher B., Tanguay, Jean‐Francois, Montalescot, Gilles, Faxon, David P., Jolly, Sanjit S., Widimsky, Petr, Niemela, Kari, Steg, Philippe Gabriel, Natarajan, Madhu K., Gao, Peggy, Fox, Keith A. A., Yusuf, Salim, Mehta, Shamir R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721756/
https://www.ncbi.nlm.nih.gov/pubmed/29101117
http://dx.doi.org/10.1161/JAHA.117.006577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721756/
https://www.ncbi.nlm.nih.gov/pubmed/29101117
http://dx.doi.org/10.1161/JAHA.117.006577

Ejemplares similares